Literature DB >> 28811696

Relationship Between Fetal Loss and Serum Gonadal Hormones Level in Experimental Antiphospholipid Syndrome Mouse.

Shanmugam Velayuthaprabhu1, Arunachalam Chinnathambi2, Sulaiman Ali Alharbi2, Hidehiko Matsubayashi3, Govindaraju Archunan1.   

Abstract

To investigate the effects of antiphospholipid antibodies on establishment of pregnancy and changes in hormones such as estradiol-17ß (E2) and progesterone (P) levels in circulation. Hence, mice were immunized with human β2-Glycoprotein I (β2GPI) and the effect of these antibodies on fetuses weight, placental obsrvation, Serum levels of P and E2 in pregnant mice, hematological were observed. Immunization of mice with human β2-GPI resulted in elevated levels of antiphospholipid antibodies. The experimentally induced antiphospholipid syndrome mouse showed higher rate of fetal resorption, low number of viable fetuses, and "placental abnormalities". In these animals, serum E2 and P levels were reduced significantly. In addition, the blood cell variation among APS induced and control mice were determined. No significant variations were observed in number of Red Blood Cell count, White Blood Cell count and Hemoglobin content, while platelet number was significantly reduced as compared to control. These results clearly demonstrate that human β2-GPI might be involved in causing gestational failure in APS by exerting their effect on serum hormones.

Entities:  

Keywords:  Anticardiolipin antibodies; Antiphospholipid syndrome; Fetal loss; Hormonal imbalance; Recurrent pregnancy loss; SLE

Year:  2016        PMID: 28811696      PMCID: PMC5539012          DOI: 10.1007/s12291-016-0618-1

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  25 in total

1.  Effect of sera from women with systemic lupus erythematosus or antiphospholipid syndrome and recurrent abortions on human placental explants in culture.

Authors:  Sarah Yacobi; Asher Ornoy; Zeev Blumenfeld; Richard K Miller
Journal:  Teratology       Date:  2002-12

2.  IgG anti-cardiolipin antibodies in murine lupus.

Authors:  A E Gharavi; R C Mellors; K B Elkon
Journal:  Clin Exp Immunol       Date:  1989-11       Impact factor: 4.330

Review 3.  Oestrogen and human implantation.

Authors:  D H Edgar
Journal:  Hum Reprod       Date:  1995-01       Impact factor: 6.918

4.  Thrombosis, abortion, cerebral disease, and the lupus anticoagulant.

Authors:  G R Hughes
Journal:  Br Med J (Clin Res Ed)       Date:  1983-10-15

5.  Inadequate production of progesterone in women with systemic lupus erythematosus.

Authors:  F Arnalich; S Benito-Urbina; P Gonzalez-Gancedo; E Iglesias; E de Miguel; J Gijon-Baños
Journal:  Br J Rheumatol       Date:  1992-04

6.  Defective maternal-fetal interaction in a murine autoimmune model.

Authors:  B Tartakovsky; B L Bermas; Z Sthoeger; G M Shearer; E Mozes
Journal:  Hum Reprod       Date:  1996-11       Impact factor: 6.918

7.  Steroid hormones and disease activity during pregnancy in systemic lupus erythematosus.

Authors:  Andrea Doria; Maurizio Cutolo; Anna Ghirardello; Sandra Zampieri; Francesca Vescovi; Alberto Sulli; Massimo Giusti; Antonio Piccoli; Pasquale Grella; Pier Franca Gambari
Journal:  Arthritis Rheum       Date:  2002-04-15

8.  Effect of beta2-glycoprotein I null mutation on reproductive outcome and antiphospholipid antibody-mediated pregnancy pathology in mice.

Authors:  Sarah A Robertson; Claire T Roberts; Eline van Beijering; Katherine Pensa; Yonghua Sheng; Tong Shi; Steven A Krilis
Journal:  Mol Hum Reprod       Date:  2004-04-20       Impact factor: 4.025

9.  Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus.

Authors:  M D Lockshin; M L Druzin; S Goei; T Qamar; M S Magid; L Jovanovic; M Ferenc
Journal:  N Engl J Med       Date:  1985-07-18       Impact factor: 91.245

10.  Increased levels of 16 alpha-hydroxyestrone-modified proteins in pregnancy and in systemic lupus erythematosus.

Authors:  R Bucala; R G Lahita; J Fishman; A Cerami
Journal:  J Clin Endocrinol Metab       Date:  1985-05       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.